{"ok":true,"trend":{"id":679840,"platform":"news","region":"global","key":"health brief: drugmakers unscathed by trump’s drug price plan","title":"Health Brief: Drugmakers unscathed by Trump’s drug price plan","url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxOYkhMeURyRVpOSUhveTdWc1RjUXBrQkJRNFBhWTFaLVItdUh0RjNrdWRmUjdERHNaLXZhSkFLeVNkWkRBV2tOYnE5UlgzalF1ckxtdzJQaTFtemZGeWU3Z3lRVjZMSGh4OWY2Zk5kbzdUaG5DdTd6UWNxY3FlSGU4dE5PM2Q4c3JObjJ4TlJ4RHFCSk0yb3hRWHY1Y04yanNwVnlfRy1Ealpob2dnZkFJeFNtbE03b21HWlJOeTZ6emNUcWN5c1F6ZS01cw?oc=5","first_seen":"2026-10-02T02:09:40.700351Z","last_seen":"2026-10-02T09:04:50.121158Z","last_rank":31,"peak_rank":16,"last_volume":null,"peak_volume":0,"seen_count":6,"score":0.90625,"category_hint":"health","section":"health","category":"health","summary":"A health brief from The Washington Post reports that pharmaceutical companies have emerged largely unscathed from the Trump administration's drug price plan. The item suggests the plan has had minimal impact on drugmakers so far, contrary to expectations that pricing reforms would hurt the industry.","why":"Readers are watching how Trump's drug pricing policy affects the pharmaceutical industry.","tone":"neutral","entities":["Trump administration","drugmakers","The Washington Post"],"summarized_at":"2026-10-02T08:13:57.214076Z","meta":{"via":"scan","lang":"en","term":"health","source":"The Washington Post","published":"Fri, 02 Oct 2026 04:37:00 GMT"},"nw":null,"promo":null,"kind":null,"importance":null,"hidden":false,"hide_reason":null,"judged_at":null,"title_en":"Drugmakers largely unscathed by Trump drug price plan","section_name":"Health","category_name":"Health","timeline":[{"captured_at":"2026-10-02T02:09:40.700351Z","rank":30,"volume":null},{"captured_at":"2026-10-02T03:35:11.501406Z","rank":28,"volume":null},{"captured_at":"2026-10-02T04:57:48.039539Z","rank":18,"volume":null},{"captured_at":"2026-10-02T06:19:48.178742Z","rank":16,"volume":null},{"captured_at":"2026-10-02T07:42:31.297127Z","rank":29,"volume":null},{"captured_at":"2026-10-02T09:04:50.121158Z","rank":31,"volume":null}],"posts":[{"platform":"news","url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxOYkhMeURyRVpOSUhveTdWc1RjUXBrQkJRNFBhWTFaLVItdUh0RjNrdWRmUjdERHNaLXZhSkFLeVNkWkRBV2tOYnE5UlgzalF1ckxtdzJQaTFtemZGeWU3Z3lRVjZMSGh4OWY2Zk5kbzdUaG5DdTd6UWNxY3FlSGU4dE5PM2Q4c3JObjJ4TlJ4RHFCSk0yb3hRWHY1Y04yanNwVnlfRy1Ealpob2dnZkFJeFNtbE03b21HWlJOeTZ6emNUcWN5c1F6ZS01cw?oc=5","author":"The Washington Post","title":"Health Brief: Drugmakers unscathed by Trump’s drug price plan","snippet":null,"posted_at":"2026-10-02T00:51:21Z","likes":null}],"elsewhere":[],"window":"7d"}}